Location History:
- Ciudad de la Habana, CU (2010)
- Cuidad de la Habana, CU (2013)
Company Filing History:
Years Active: 2010-2013
Title: Innovator Hector Santana Milian: Pioneering Pharmaceutical Solutions
Introduction: Hector Santana Milian is a prominent inventor based in Ciudad de la Habana, Cuba, known for his significant contributions to the field of pharmaceutical formulations. With two patents to his name, Milian's innovations have had a profound impact on medical treatments, particularly in the areas of chronic wounds and neoplastic growths.
Latest Patents: Milian's latest patents include:
1. **Stabilized Pharmaceutical Formulations:** This invention pertains to stable pharmaceutical formulations that utilize recombinant interferons gamma and alpha in synergistic proportions. These formulations can be administered through parenteral routes or topically in the form of gels, ointments, or creams. The formulations aim to treat both malignant and benign pathological growths in tissues or organs, providing a significant therapeutic advancement.
2. **Use of Pharmaceutical Composition Containing Epidermal Growth Factor (EGF):** This patent addresses the innovative use of Epidermal Growth Factor (EGF) in injectable compositions designed to infiltrate chronic cutaneous ischaemic lesions. The goal of this invention is to prevent diabetic foot amputations and enhance the healing processes in surgical areas impacted by prolonged ischaemia. The compositions not only improve the tissue microenvironment but also stimulate cell proliferation, making them valuable in various medical fields, including vascular angiology, dermatology, and reconstructive surgery.
Career Highlights: Milian is currently affiliated with the Centro de Ingenieria Genetica y Biotecnologia, where he continues to advance research in biotechnology and pharmacology. His work has focused on developing innovative solutions that address critical medical challenges, particularly in the management of chronic wounds and cancer treatment.
Collaborations: Throughout his career, Milian has collaborated with esteemed colleagues such as Jorge Amador Berlanga Acosta and Jose Ignacio Fernandez Montequin. Their joint efforts and expertise contribute to the advancement of knowledge and innovations in their respective fields.
Conclusion: Hector Santana Milian exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only reflect his commitment to advancing medical science but also highlight the vital role of inventors in improving patient care and treatment outcomes. As he continues his work in Cuba, Milian's contributions are likely to inspire further research and developments in the field of biotechnology.